• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三氯生:抗疟化疗的一针强心剂。

Triclosan: a shot in the arm for antimalarial chemotherapy.

作者信息

Rao Satish P Ramachandra, Surolia Avadhesha, Surolia Namita

机构信息

Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India.

出版信息

Mol Cell Biochem. 2003 Nov;253(1-2):55-63. doi: 10.1023/a:1026049217966.

DOI:10.1023/a:1026049217966
PMID:14619956
Abstract

In order that malaria be successfully contained, it is important that one has a clear understanding of the normal physiology and biochemistry of the parasite essential to its survival in its human host. Until very recently, the conventional approaches to antimalarial chemotherapy have consistently been plagued with the uncanny ability of the parasite to evolve resistance to drugs. The recently discovered plasmodial fatty acid biosynthetic pathway as well as its inhibition by triclosan that classifies it as belonging to type II, provide with a very crucial breakthrough to the crusade against malaria. How triclosan could tilt the balance in favor of the human hosts of the malarial parasite in a malarial condition is discussed.

摘要

为了成功控制疟疾,重要的是要清楚了解疟原虫在人类宿主中生存所必需的正常生理和生物化学过程。直到最近,传统的抗疟化疗方法一直受到疟原虫对药物产生耐药性这一不可思议能力的困扰。最近发现的疟原虫脂肪酸生物合成途径及其被三氯生抑制(这使其属于II型),为抗击疟疾的斗争提供了一个非常关键的突破。本文讨论了在疟疾情况下三氯生如何能够使天平向疟原虫的人类宿主倾斜。

相似文献

1
Triclosan: a shot in the arm for antimalarial chemotherapy.三氯生:抗疟化疗的一针强心剂。
Mol Cell Biochem. 2003 Nov;253(1-2):55-63. doi: 10.1023/a:1026049217966.
2
Paradigm shifts in malaria parasite biochemistry and anti-malarial chemotherapy.疟原虫生物化学与抗疟化疗的范式转变
Bioessays. 2002 Feb;24(2):192-6. doi: 10.1002/bies.10042.
3
Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum.三氯生通过抑制恶性疟原虫的烯酰-ACP还原酶,为疟疾的血液阶段提供保护。
Nat Med. 2001 Feb;7(2):167-73. doi: 10.1038/84612.
4
Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.疟疾化疗的现状以及药理学在抗疟药物研发中的作用。
Fundam Clin Pharmacol. 2009 Aug;23(4):387-409. doi: 10.1111/j.1472-8206.2009.00709.x.
5
Malaria pulls a FASt one.疟疾耍了个花招。
Cell Host Microbe. 2008 Dec 11;4(6):509-11. doi: 10.1016/j.chom.2008.11.006.
6
Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors.恶性疟原虫烯脂酰-ACP还原酶与其底物及抑制剂相互作用的动力学决定因素。
Biochem Biophys Res Commun. 2001 Dec 14;289(4):832-7. doi: 10.1006/bbrc.2001.6061.
7
Plasmodial heat shock proteins: targets for chemotherapy.疟原虫热休克蛋白:化疗靶点
FEMS Immunol Med Microbiol. 2010 Feb;58(1):61-74. doi: 10.1111/j.1574-695X.2009.00639.x. Epub 2009 Nov 30.
8
The plastid of Plasmodium spp.: a target for inhibitors.
Curr Top Microbiol Immunol. 2005;295:251-73. doi: 10.1007/3-540-29088-5_10.
9
3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.3,5-双(亚苄基)-4-哌啶酮及相关的 N-酰基类似物:一组针对恶性疟原虫肝期的新型抗疟药物。
Bioorg Med Chem. 2013 Dec 1;21(23):7250-6. doi: 10.1016/j.bmc.2013.09.065. Epub 2013 Oct 8.
10
New agents to combat malaria.
Nat Med. 2001 Feb;7(2):149-50. doi: 10.1038/84573.

引用本文的文献

1
Current advances in detection and treatment of babesiosis.巴贝斯虫病的检测和治疗的最新进展。
Curr Med Chem. 2012;19(10):1504-18. doi: 10.2174/092986712799828355.
2
Mutational analysis of the triclosan-binding region of enoyl-ACP (acyl-carrier protein) reductase from Plasmodium falciparum.恶性疟原虫烯脂酰-ACP(酰基载体蛋白)还原酶三氯生结合区域的突变分析。
Biochem J. 2004 Aug 1;381(Pt 3):735-41. doi: 10.1042/BJ20040302.

本文引用的文献

1
Emerging targets for antimalarial drugs.
Expert Opin Ther Targets. 2001 Aug;5(4):423-441. doi: 10.1517/14728222.5.4.423.
2
Effects of triclosan/copolymer dentifrice on dental plaque and gingivitis in a 3-month randomized controlled clinical trial: influence of baseline gingivitis on observed efficacy.三氯生/共聚物牙膏对牙菌斑和牙龈炎影响的3个月随机对照临床试验:基线牙龈炎对观察疗效的影响
J Clin Dent. 2002;13(4):167-78.
3
Experimental gingivitis studies: effects of triclosan and triclosan-containing dentifrices on dental plaque and gingivitis in three-week randomized controlled clinical trials.实验性牙龈炎研究:在为期三周的随机对照临床试验中三氯生及含三氯生牙膏对牙菌斑和牙龈炎的影响
J Clin Dent. 2002;13(4):158-66.
4
Triclosan/pyrophosphate dentifrice: dental plaque and gingivitis effects in a 6-month randomized controlled clinical study.三氯生/焦磷酸盐牙膏:一项为期6个月的随机对照临床研究中对牙菌斑和牙龈炎的影响
J Clin Dent. 2002;13(4):149-57.
5
Aquatic toxicity of triclosan.三氯生的水生毒性。
Environ Toxicol Chem. 2002 Jul;21(7):1338-49.
6
Determination of triclosan in personal health care products by liquid chromatography (HPLC).采用液相色谱法(HPLC)测定个人护理产品中的三氯生。
Farmaco. 2002 May;57(5):369-72. doi: 10.1016/s0014-827x(02)01225-9.
7
An in vitro oral biofilm model for comparing the efficacy of antimicrobial mouthrinses.一种用于比较抗菌漱口水功效的体外口腔生物膜模型。
Caries Res. 2002 Mar-Apr;36(2):93-100. doi: 10.1159/000057866.
8
The antimicrobial properties of a urea-based handwash lotion with triclosan.
Gen Dent. 2001 Nov-Dec;49(6):653-6.
9
Inhibitors of fatty acid synthesis as antimicrobial chemotherapeutics.作为抗菌化疗药物的脂肪酸合成抑制剂
Appl Microbiol Biotechnol. 2002 May;58(6):695-703. doi: 10.1007/s00253-001-0918-z. Epub 2002 Mar 7.
10
Susceptibility of antibiotic-resistant cocci to biocides.耐抗生素球菌对杀菌剂的敏感性。
J Appl Microbiol. 2002;92 Suppl:158S-62S.